Security Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,214
Closed -$231K 217
2026
Q1
$231K Buy
+8,214
New +$219K 0.04% 181
2024
Q1
Sell
-7,267
Closed -$209K 190
2023
Q4
$209K Buy
7,267
+928
+15% +$28.1K 0.05% 160
2023
Q3
$210K Sell
6,339
-857
-12% -$30.3K 0.06% 156
2023
Q2
$264K Buy
7,196
+787
+12% +$30.6K 0.07% 126
2023
Q1
$261K Hold
6,409
0.08% 121
2022
Q4
$328K Hold
6,409
0.1% 116
2022
Q3
$280K Sell
6,409
-88
-1% -$4.28K 0.1% 116
2022
Q2
$341K Sell
6,497
-100
-2% -$5.1K 0.11% 104
2022
Q1
$342K Sell
6,597
-60
-0.9% -$3.11K 0.11% 105
2021
Q4
$393K Buy
+6,657
New +$330K 0.13% 93

Other funds holding PFE

Security Financial Services's PFE Position: Q2 2026 in Review

Security Financial Services sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,214 shares — an estimated $231K sold.

Security Financial Services first reported a position in PFE in Q4 2021 and held it in 10 quarters. The position peaked at $393K in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Security Financial Services reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Security Financial Services sold 8,214 Pfizer shares in Q2 2026, an estimated $231K.
  • Security Financial Services first reported a position in Pfizer in Q4 2021 and held it in 10 quarters.
  • Security Financial Services's Pfizer position peaked at $393K in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Security Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.